Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-26366
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVoss, Moritz-
dc.contributor.authorHüppi, Sean-
dc.contributor.authorSchaub, Daniela-
dc.contributor.authorHayashi, Takahiro-
dc.contributor.authorLigibel, Mathieu-
dc.contributor.authorSager, Emine-
dc.contributor.authorSchroer, Kirsten-
dc.contributor.authorSnajdrova, Radka-
dc.contributor.authorBuller, Rebecca-
dc.date.accessioned2022-12-09T13:33:56Z-
dc.date.available2022-12-09T13:33:56Z-
dc.date.issued2022-
dc.identifier.issn1867-3880de_CH
dc.identifier.issn1867-3899de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/26366-
dc.description.abstractEnzymatic late-stage diversification of small molecules has the potential to rapidly generate diversity in compound libraries dedicated to drug discovery. In this context, freestanding Fe(II)/α-ketoglutarate-dependent halogenases have raised particular interest as this enzyme family allows the otherwise difficult regio- and stereoselective halogenation of unactivated C(sp3)-H bonds. Here, we report the development of two engineered variants of the halogenase WelO5* for the racemic resolution of a mixture of stereoisomers generated in the synthesis of a bioactive martinelline-derived fragment. By screening a 3-site combinatorial variant library, we could identify two variants exhibiting exquisite substrate selectivity towards the desired enantiomers. Strikingly, the inversion of substrate stereopreference between the halogenase variants was achieved by varying only three residues in the active site. Protein crystallization and subsequent structure elucidation of the wildtype enzyme and a WelO5* variant shed light on the factors governing substrate acceptance and selectivity.de_CH
dc.language.isoende_CH
dc.publisherWileyde_CH
dc.relation.ispartofChemCatChemde_CH
dc.rightshttp://creativecommons.org/licenses/by/4.0/de_CH
dc.subjectBiocatalysisde_CH
dc.subjectEnzyme engineeringde_CH
dc.subject.ddc660.6: Biotechnologiede_CH
dc.titleEnzyme engineering enables inversion of substrate stereopreference of the halogenase WelO5*de_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.1002/cctc.202201115de_CH
dc.identifier.doi10.21256/zhaw-26366-
zhaw.funding.euNode_CH
zhaw.issue24de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.starte202201115de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume14de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.funding.snf180544de_CH
zhaw.webfeedBiokatalysede_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
2022_Voss-etal_Enzyme-engineering-substrate-stereopreference-inversion-halogenase-WelO5.pdf1.84 MBAdobe PDFThumbnail
View/Open
Show simple item record
Voss, M., Hüppi, S., Schaub, D., Hayashi, T., Ligibel, M., Sager, E., Schroer, K., Snajdrova, R., & Buller, R. (2022). Enzyme engineering enables inversion of substrate stereopreference of the halogenase WelO5*. ChemCatChem, 14(24), e202201115. https://doi.org/10.1002/cctc.202201115
Voss, M. et al. (2022) ‘Enzyme engineering enables inversion of substrate stereopreference of the halogenase WelO5*’, ChemCatChem, 14(24), p. e202201115. Available at: https://doi.org/10.1002/cctc.202201115.
M. Voss et al., “Enzyme engineering enables inversion of substrate stereopreference of the halogenase WelO5*,” ChemCatChem, vol. 14, no. 24, p. e202201115, 2022, doi: 10.1002/cctc.202201115.
VOSS, Moritz, Sean HÜPPI, Daniela SCHAUB, Takahiro HAYASHI, Mathieu LIGIBEL, Emine SAGER, Kirsten SCHROER, Radka SNAJDROVA und Rebecca BULLER, 2022. Enzyme engineering enables inversion of substrate stereopreference of the halogenase WelO5*. ChemCatChem. 2022. Bd. 14, Nr. 24, S. e202201115. DOI 10.1002/cctc.202201115
Voss, Moritz, Sean Hüppi, Daniela Schaub, Takahiro Hayashi, Mathieu Ligibel, Emine Sager, Kirsten Schroer, Radka Snajdrova, and Rebecca Buller. 2022. “Enzyme Engineering Enables Inversion of Substrate Stereopreference of the Halogenase WelO5*.” ChemCatChem 14 (24): e202201115. https://doi.org/10.1002/cctc.202201115.
Voss, Moritz, et al. “Enzyme Engineering Enables Inversion of Substrate Stereopreference of the Halogenase WelO5*.” ChemCatChem, vol. 14, no. 24, 2022, p. e202201115, https://doi.org/10.1002/cctc.202201115.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.